共 253 条
[1]
Weinmann M(2003)Treatment of lung cancer in the elderly. Part I: non-small cell lung cancer Lung Cancer 39 233-253
[2]
Jeremic B(2013)Clinical use of crizotinib for the treatment of non-small cell lung cancer Biologics 7 91-101
[3]
Toomes H(2011)Biomarker analyses and final overall survival results from a phase III, randomized, open-label, first-line study of gefitinib versus carboplatin/paclitaxel in clinically selected patients with advanced non-small-cell lung cancer in Asia (IPASS) J Clin Oncol 29 2866-2874
[4]
Friedel G(2001)Response to chemotherapy, quality of life benefits and survival in advanced non-small cell lung cancer: review of literature results Lung Cancer 34 S95-S101
[5]
Bamberg M(2012)Crizotinib for the treatment of patients with advanced non-small cell lung cancer Drugs Today (Barc) 48 271-282
[6]
Roberts PJ(2014)Role of PAX8 in the regulation of MET and RON receptor tyrosine kinases in non-small cell lung cancer BMC Cancer 14 185-566
[7]
Fukuoka M(2007)Identification of the transforming EML4-ALK fusion gene in non-small-cell lung cancer Nature 448 561-1203
[8]
Wu YL(2007)Global survey of phosphotyrosine signaling identifies oncogenic kinases in lung cancer Cell 131 1190-2402
[9]
Thongprasert S(2014)ALK-positive non-small cell lung cancer: Mechanisms of resistance and emerging treatment options Cancer 120 2392-1046
[10]
Sunpaweravong P(2013)Activity of EGFR-tyrosine kinase and ALK inhibitors for EML4-ALK-rearranged non-small-cell lung cancer harbored coexisting EGFR mutation BMC Cancer 13 262-643